AQR Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Sell |
21,614
-3,692
| -15% | -$180K | ﹤0.01% | 2179 |
|
|
2025
Q1 | $861K | Buy |
+25,306
| New | +$861K | ﹤0.01% | 2124 |
|
|
2022
Q3 | – | Sell |
-8,505
| Closed | -$517K | – | 2222 |
|
|
2022
Q2 | $517K | Sell |
8,505
-578
| -6% | -$35.1K | ﹤0.01% | 1672 |
|
|
2022
Q1 | $570K | Buy |
9,083
+2,310
| +34% | +$145K | ﹤0.01% | 1770 |
|
|
2021
Q4 | $513K | Buy |
6,773
+2,911
| +75% | +$220K | ﹤0.01% | 1817 |
|
|
2021
Q3 | $432K | Buy |
3,862
+1,661
| +75% | +$186K | ﹤0.01% | 1917 |
|
|
2021
Q2 | $356K | Buy |
+2,201
| New | +$356K | ﹤0.01% | 1998 |
|